Upstream Bio UPB
NASDAQ UPB
$5.04 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Upstream Bio (UPB) Price to Sales (2024 - 2026)

Updated

Upstream Bio's Price to Sales was 120.02 in Q2 2026, down 44.7% from 216.93 a year earlier and down 18.6% from the prior quarter.

Analysis

Upstream Bio (UPB) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Upstream Bio came in at 515.96, up 443.6% from FY2024.

  • In earlier years, Price to Sales was 94.91 in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Price to Sales since Q4 2024.
  • Per Business Quant data, UPB's Price to Sales in the three quarters before Q2 2026 was 147.44 (Q1 2026), 515.96 (Q4 2025) and 362.89 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Upstream Bio 276.05 Mn 276.05 Mn -3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.02
Mar 31, 2026 147.44
Dec 31, 2025 515.96
Sep 30, 2025 362.89
Jun 30, 2025 216.93
Mar 31, 2025 142.98
Dec 31, 2024 94.91
API Access

Upstream Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=UPB&period=max&api_key=YOUR_API_KEY